Given that chemoresistance is associated with cold tumours withdecreased expression of IFN1 genes and lower density ofCD8+ TILs, we hypothesised that response tochemotherapy and OS can be improved via the addition of STING agonist to thetreatment regime. Here, STING1 is linked to neoplasm.